| 发明名称 | Method for use in the treatment of aneurysm | ||
| 摘要 | The present invention relates to a compound which is an antagonist of IL-1 beta or an inhibitor of IL-1 beta expression for use in the treatment or the prevention of aneurysm. In another embodiment, the invention relates to a pharmaceutical composition for use in the treatment or the prevention of aneurysm comprising an antagonist of IL-1 beta or an inhibitor of IL-1 beta expression. | ||
| 申请公布号 | US9573997(B2) | 申请公布日期 | 2017.02.21 |
| 申请号 | US201314386250 | 申请日期 | 2013.03.15 |
| 申请人 | INSERM (Institut National de la Sante et de la Recherche Medicale);Universite Paris Descartes | 发明人 | Mallat Ziad;Taleb Soraya;Tedgui Alain |
| 分类号 | A61K38/20;A61P9/00;C07K16/24;C07K14/545;A61K39/00 | 主分类号 | A61K38/20 |
| 代理机构 | Whitham, Curtis & Cook, P.C. | 代理人 | Whitham, Curtis & Cook, P.C. |
| 主权项 | 1. A method of treating an abdominal aortic aneurysm in a subject in need thereof, consisting essentially of administering to said subject a therapeutically effective amount of a compound which is an antagonist of IL-1 beta, wherein the antagonist is an anti-IL-1 beta antibody specific for IL-1 beta. | ||
| 地址 | Paris FR | ||